United Guardian (UG) Profit After Tax (QoQ) (2010 - 2026)
Powered by 
Analysis
United Guardian (UG) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.03% |
| Mar 31, 2026 | 26.07% |
| Dec 31, 2025 | 141.98% |
| Sep 30, 2025 | -57.17% |
| Jun 30, 2025 | 11.75% |
| Mar 31, 2025 | 11.35% |
| Dec 31, 2024 | -41.80% |
| Sep 30, 2024 | -9.49% |
| Jun 30, 2024 | 3.33% |
| Mar 31, 2024 | 25.49% |
| Dec 31, 2023 | 17.66% |
| Sep 30, 2023 | 35.93% |
| Jun 30, 2023 | -39.02% |
| Mar 31, 2023 | 11.32% |
| Dec 31, 2022 | 96.58% |
| Sep 30, 2022 | -45.44% |
| Jun 30, 2022 | -30.52% |
| Mar 31, 2022 | -18.35% |
| Dec 31, 2021 | 9.82% |
| Sep 30, 2021 | -24.40% |